{"id":"W2109151188","doi":"10.1038/leu.2009.205","title":"Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia","year":2009,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Queen Elizabeth II Health Sciences Centre; Moncton Hospital; Hôpital Charles-Le Moyne; Alberta Cancer Foundation; McGill University Health Centre","funders":"National Cancer Institute","keywords":"Fludarabine; Chronic lymphocytic leukemia; Medicine; Leukemia; Vidarabine; Hematology; Internal medicine; Immunology; Oncology; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0003713782,0.001581541,0.002362917,0.00126077,0.0001443449,0.0001463894,0.0009701693,0.002704616,0.0007921753],"category_scores_gemma":[0.0001557536,0.001281327,0.0004003913,0.001780566,0.0004864424,0.0002626124,0.0002608098,0.005048246,0.001367053],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.6133346,"about_ca_system_score_gemma":0.1672504,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007817006,"about_ca_topic_score_gemma":0.000463635,"domain_scores_codex":[0.9908865,0.0002841341,0.001350531,0.002056558,0.00264668,0.002775577],"domain_scores_gemma":[0.9957653,0.0003247205,0.0004833807,0.002429163,0.0004984543,0.0004989612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001724945,0.000132634,0.001685642,0.00233075,0.0002999091,0.01697442,0.0001418332,0.001527114,0.00008550042,0.000005087827,0.9702125,0.004879695],"study_design_scores_gemma":[0.2341268,0.004482449,0.006214883,0.004548542,0.001098892,0.0008464692,0.00002039735,0.0250279,0.001443165,0.00009076835,0.719058,0.003041741],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.9167254,0.003035827,0.00003953498,0.03544606,0.0008126073,0.007837848,0.0002563401,0.001145422,0.03470099],"genre_scores_gemma":[0.3617057,0.0007100877,0.001185121,0.5236372,0.00798393,0.0005874743,0.01450373,0.001399161,0.08828764],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5550197,"threshold_uncertainty_score":0.9996933,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01014922425182741,"score_gpt":0.2444044571314968,"score_spread":0.2342552328796694,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}